Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MJT.0000000000001969 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Neuroprotective Agents With Reperfusion Therapies in Ischemic Stroke: Evidence From Recent Randomized Trials.
Cureus
July 2025
Medicine and Surgery, King Edward Medical University, Lahore, PAK.
This systematic review evaluates the effectiveness and safety of adjunctive neuroprotective therapies administered in combination with reperfusion treatments, either intravenous (IV) thrombolysis, mechanical thrombectomy, or both, in adult patients with acute ischemic stroke (AIS). Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a comprehensive search of four major databases was conducted with filters applied to include English-language randomized controlled trials (RCTs) published within the last five years. From an initial 622 records, 10 eligible RCTs were identified and analyzed.
View Article and Find Full Text PDFNelonemdaz as a Neuroprotective Agent in Acute Ischemic Stroke: A Meta-analysis of RODIN and SONIC Trials.
Am J Ther
May 2025
Department of Medicine, Bacha Khan Medical College, Mardan, Pakistan.
Nelonemdaz Treatment in Out-of-Hospital Cardiac Arrest: The Quest for the Grail Continues.
Crit Care Med
April 2025
Division of Emergency Critical Care, Department of Emergency Medicine, Stony Brook University Hospital, Garden City Park, NY.
Neuroprotection during Thrombectomy for Acute Ischemic Stroke: A Review of Future Therapies.
Int J Mol Sci
January 2024
Department of Anesthesiology, Stony Brook University Hospital, Stony Brook, NY 11794, USA.
Stroke is a major cause of death and disability worldwide. Endovascular thrombectomy has been impactful in decreasing mortality. However, many clinical results continue to show suboptimal functional outcomes despite high recanalization rates.
View Article and Find Full Text PDFThe Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy.
J Stroke
January 2023
Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Background And Purpose: Nelonemdaz (Neu2000) has both selective antagonism against 2B subunit of N-methyl-D-aspartate receptor and antioxidant activity. This drug provides sufficient evidence of neuroprotection in acute cerebral ischemia/reperfusion models. This phase III trial aims to determine this effect in patients.
View Article and Find Full Text PDF